FILOSTO, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 13.447
AS - Asia 6.623
EU - Europa 3.520
SA - Sud America 1.580
Continente sconosciuto - Info sul continente non disponibili 361
AF - Africa 148
OC - Oceania 12
Totale 25.691
Nazione #
US - Stati Uniti d'America 13.014
SG - Singapore 2.645
CN - Cina 1.377
BR - Brasile 1.319
HK - Hong Kong 972
IT - Italia 764
VN - Vietnam 458
BD - Bangladesh 380
UA - Ucraina 357
GB - Regno Unito 353
DE - Germania 336
FR - Francia 318
PL - Polonia 292
FI - Finlandia 276
RU - Federazione Russa 270
TR - Turchia 263
IE - Irlanda 225
CA - Canada 206
IN - India 141
MX - Messico 87
AR - Argentina 86
SE - Svezia 70
IQ - Iraq 64
ZA - Sudafrica 62
NL - Olanda 55
AT - Austria 49
JP - Giappone 48
EC - Ecuador 42
ID - Indonesia 40
CO - Colombia 34
ES - Italia 32
PK - Pakistan 32
UZ - Uzbekistan 28
PY - Paraguay 27
CR - Costa Rica 25
CZ - Repubblica Ceca 25
JM - Giamaica 25
SA - Arabia Saudita 24
VE - Venezuela 23
CL - Cile 22
AE - Emirati Arabi Uniti 18
CH - Svizzera 16
EG - Egitto 16
IL - Israele 16
HN - Honduras 15
LT - Lituania 14
KE - Kenya 13
MA - Marocco 12
PE - Perù 12
UY - Uruguay 12
EE - Estonia 11
JO - Giordania 11
NP - Nepal 11
PH - Filippine 11
AU - Australia 10
PT - Portogallo 10
TN - Tunisia 10
TW - Taiwan 10
SV - El Salvador 9
BE - Belgio 8
BH - Bahrain 8
GR - Grecia 8
GT - Guatemala 8
KZ - Kazakistan 8
NG - Nigeria 8
NI - Nicaragua 8
AL - Albania 7
DO - Repubblica Dominicana 7
LB - Libano 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
ET - Etiopia 6
OM - Oman 6
PA - Panama 6
PR - Porto Rico 6
BS - Bahamas 5
DZ - Algeria 5
MY - Malesia 5
SN - Senegal 5
GE - Georgia 4
IR - Iran 4
MD - Moldavia 4
MU - Mauritius 4
PS - Palestinian Territory 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
EU - Europa 3
KH - Cambogia 3
LV - Lettonia 3
RO - Romania 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BO - Bolivia 2
BZ - Belize 2
CG - Congo 2
DK - Danimarca 2
GD - Grenada 2
GP - Guadalupe 2
Totale 25.298
Città #
Ashburn 1.355
Fairfield 1.313
Singapore 1.282
Hong Kong 970
San Jose 757
Woodbridge 687
Council Bluffs 667
Seattle 611
Houston 554
The Dalles 482
Wilmington 454
Cambridge 432
Princeton 407
New York 358
Warsaw 289
Jacksonville 279
Los Angeles 268
Lauterbourg 251
Beijing 248
Istanbul 223
Dublin 216
Ann Arbor 214
Helsinki 191
Dallas 177
Chandler 151
Ho Chi Minh City 146
Santa Clara 138
Des Moines 137
Buffalo 122
Moscow 113
Redondo Beach 105
Columbus 103
São Paulo 102
Brescia 94
San Diego 94
Hanoi 91
London 83
Munich 83
Chicago 74
Milan 73
North Bergen 70
Atlanta 69
Phoenix 66
Shanghai 61
Rome 58
Toronto 57
San Francisco 54
Brooklyn 52
Nanjing 51
Boardman 49
Nuremberg 48
Montreal 46
Rio de Janeiro 46
Orem 43
Tokyo 41
Turku 40
Denver 38
Naples 33
Johannesburg 31
Lappeenranta 28
Frankfurt am Main 27
Guangzhou 27
Porto Alegre 27
Tashkent 27
Belo Horizonte 26
Brasília 26
Vienna 26
Pune 25
Baghdad 23
Chennai 23
Dhaka 23
Mexico City 23
Romola 23
Stockholm 23
Dearborn 22
Poplar 22
Manchester 21
Curitiba 20
Da Nang 20
Miami 20
San José 20
Tianjin 20
Boston 19
Guayaquil 19
Changsha 18
Norwalk 18
Washington 18
Charlotte 17
Amsterdam 16
Nanchang 16
Salt Lake City 16
Goiânia 15
Guarulhos 15
Haiphong 15
Jinan 15
New Delhi 15
Shenyang 15
Philadelphia 14
Tampa 14
Kingston 13
Totale 16.177
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 380
Very late-onset friedreich ataxia with laryngeal dystonia 324
A Novel Mutation in the Stalk Domain of KIF5A Causes a Slowly Progressive Atypical Motor Syndrome 281
COVID-19 impact on consecutive neurological patients admitted to the emergency department 273
A complex craniovertebral junction malformation in a patient with late onset glycogenosis 2 261
Critical illness myopathy 254
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 217
A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement. 209
Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy 199
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 194
A new mutation in the mitochondrial tRNAAla gene in a patient with ophthalmoplegia and dysphagia 182
Gold Coast Criteria in ALS Diagnosis: A Real-World Experience 176
A novel mitochondrial tRNA(Ala) gene variant causes chronic progressive external ophthalmoplegia in a patient with Huntington disease. 175
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 175
Small nerve fiber pathology in critical illness 172
A novel CAPN1 mutation causes a pure hereditary spastic paraplegia in an Italian family 172
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 168
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 162
Snake-Eye Myelopathy and Surgical Prognosis: Case Series and Systematic Literature Review 156
Coffee and amyotrophic lateral sclerosis: A possible preventive role 155
Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study 153
Neuropathology of mitochondrial diseases. 144
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 139
Mitochondrial DNA-related disorders. 138
Muscle pain in mitochondrial diseases: a picture from the Italian network 137
Hemangioma of the semimembranosus muscle in a patient with late-onset glycogenosis II 136
The brain in late-onset glycogenosis II: a structural and functional MRI study. 136
Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study 133
Novel mitochondrial tRNALeu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype 133
C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age 133
Human leukocyte antigens class II in CIDP spectrum neuropathies 129
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 129
Magnetic resonance imaging of the peripheral nerve 127
MR Neurography in Diagnosing Nondiabetic Lumbosacral Radiculoplexus Neuropathy 126
Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a NovelTYMPMutation: The Need for Early Diagnosis 126
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 125
Editorial: Iron and Neurodegeneration 123
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 122
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group 119
Late and severe myopathy in a patient with glycogenosis VII worsened by cyclosporin and amiodarone 119
SELENON-related myopathy as a cause of acute respiratory failure in middle age: a case report 118
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial) 118
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 118
Advances in quantitative imaging of genetic and acquired myopathies: Clinical applications and perspectives 118
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE-MTDPS1) 118
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1) 118
Psychosocial impact of sport activity in neuromuscular disorders 116
Impact of environmental factors and physical activity on disability and quality of life in CIDP 114
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 114
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis 112
Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort 111
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: Report of a family 111
Muscle biopsy displaying "double trouble" pathology: Combined features of periodic paralysis and dermatomyositis 111
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 108
Vaccination recommendations for patients with neuromuscular disease 108
A 5-year clinical follow-up study from the Italian National Registry for FSHD 107
Clinical spectrum and evolution of monoclonal gammopathy-associated neuropathy: An observational study 107
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 107
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 106
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 106
On the Comparison of Markov Chains-based Models in Process Mining for Healthcare: A Case Study 105
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: A simple test to identify this condition 105
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 104
Juvenile-Onset Recurrent Rhabdomyolysis Due to Compound Heterozygote Variants in the ACADVL Gene 103
Alterazioni delle fibre sensitive di piccolo calibro intra-epidermiche in pazienti con critical illness myopathy and neuropathy. Dati preliminari. 103
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 103
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 102
A mobile app for patients with Pompe disease and its possible clinical applications 102
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 102
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 100
What Are the Normal Serum Creatine Kinase Values for Skeletal Muscle? A Worldwide Systematic Review 100
The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy 99
A Comprehensive Update on Late-Onset Pompe Disease 98
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy 98
Prevalence of asymptomatic vertebral fractures in late-onset pompe disease 98
Late-onset glycogen storage disease type 2 98
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 97
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 97
The genetic basis of undiagnosed muscular dystrophies and myopathies 96
RELEVANCE OF DIAGNOSTIC INVESTIGATIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLIRADICULONEUROPATHY: DATA FROM THE ITALIAN CIDP DATABASE 95
Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients 95
Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe disease 94
Strategies for treating mitochondrial disorders: An update 94
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy 93
The role of mitochondria in neurodegenerative diseases 93
ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: A clinical, biochemical and molecular study 93
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience 92
Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy 92
A novel mutation in motor domain of KIF5A associated with an HSP/axonal neuropathy phenotype 91
Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase 91
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network 90
A mitochondrial DNA duplication as a marker of skeletal muscle specific mutations in the mitochondrial genome 90
Mitochondrial diseases: Advances and issues 90
A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation 90
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 89
Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy 89
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 89
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 88
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 88
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? 88
Totale 12.982
Categoria #
all - tutte 160.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022880 0 0 0 39 11 81 137 91 85 57 115 264
2022/2023860 223 22 22 21 50 266 3 53 103 13 36 48
2023/20241.565 61 29 146 57 56 267 47 45 487 27 38 305
2024/20253.934 28 11 48 503 459 322 268 87 550 360 775 523
2025/20269.042 731 1.283 719 1.287 716 497 1.179 439 504 792 518 377
2026/20273.338 431 548 775 1.584 0 0 0 0 0 0 0 0
Totale 25.691